Literature DB >> 11442301

Mild cognitive impairment: clinical features and review of screening instruments.

S Galluzzi1, L Cimaschi, L Ferrucci, G B Frisoni.   

Abstract

Clinical criteria to recognize subjects with cognitive impairment in the pre-dementia stage are becoming available. These are frail subjects, at risk of adverse outcomes, such as death, institutionalization, and functional and cognitive deterioration. Early identification of these subjects has a great importance in order to start rehabilitative or pharmacological interventions that could slow the progression of cognitive impairment, and the onset of disability. In this regard, cognitive screening tests might be helpful in different clinical settings (general practice, acute care, rehabilitation, and nursing home). We describe the most frequent clinical presentations of cognitive impairment in the pre-dementia stage, and review eleven screening tests to provide recommendations on which should be preferred in each setting.

Entities:  

Mesh:

Year:  2001        PMID: 11442301     DOI: 10.1007/BF03351477

Source DB:  PubMed          Journal:  Aging (Milano)        ISSN: 0394-9532


  7 in total

1.  Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study.

Authors:  Claudio Babiloni; Giovanni B Frisoni; Fabrizio Vecchio; Roberta Lizio; Michela Pievani; Geroldi Cristina; Claudia Fracassi; Fabrizio Vernieri; Guido Rodriguez; Flavio Nobili; Raffaele Ferri; Paolo M Rossini
Journal:  Hum Brain Mapp       Date:  2010-12-22       Impact factor: 5.038

2.  Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease.

Authors:  Claudio Babiloni; Claudio Del Percio; Marina Boccardi; Roberta Lizio; Susanna Lopez; Filippo Carducci; Nicola Marzano; Andrea Soricelli; Raffaele Ferri; Antonio Ivano Triggiani; Annapaola Prestia; Serenella Salinari; Paul E Rasser; Erol Basar; Francesco Famà; Flavio Nobili; Görsev Yener; Derya Durusu Emek-Savaş; Loreto Gesualdo; Ciro Mundi; Paul M Thompson; Paolo M Rossini; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2014-09-21       Impact factor: 4.673

3.  Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: interest of the Deco questionnaire.

Authors:  L Carcaillon; G Berrut; F Sellal; J F Dartigues; S Gillette; J J Pere; I Bourdeix
Journal:  J Nutr Health Aging       Date:  2011-05       Impact factor: 4.075

Review 4.  Dementia: issues in early recognition and intervention in primary care.

Authors:  R T Woods; Esme Moniz-Cook; Steve Iliffe; Peter Campion; Myrra Vernooij-Dassen; Orazio Zanetti; Manuel Franco
Journal:  J R Soc Med       Date:  2003-07       Impact factor: 18.000

5.  Neuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states.

Authors:  Charis Styliadis; Panagiotis Kartsidis; Evangelos Paraskevopoulos; Andreas A Ioannides; Panagiotis D Bamidis
Journal:  Neural Plast       Date:  2015-04-07       Impact factor: 3.599

6.  Parietal Fast Sleep Spindle Density Decrease in Alzheimer's Disease and Amnesic Mild Cognitive Impairment.

Authors:  Maurizio Gorgoni; Giulia Lauri; Ilaria Truglia; Susanna Cordone; Simone Sarasso; Serena Scarpelli; Anastasia Mangiaruga; Aurora D'Atri; Daniela Tempesta; Michele Ferrara; Camillo Marra; Paolo Maria Rossini; Luigi De Gennaro
Journal:  Neural Plast       Date:  2016-03-15       Impact factor: 3.599

7.  In Search of Sleep Biomarkers of Alzheimer's Disease: K-Complexes Do Not Discriminate between Patients with Mild Cognitive Impairment and Healthy Controls.

Authors:  Flaminia Reda; Maurizio Gorgoni; Giulia Lauri; Ilaria Truglia; Susanna Cordone; Serena Scarpelli; Anastasia Mangiaruga; Aurora D'Atri; Michele Ferrara; Giordano Lacidogna; Camillo Marra; Paolo Maria Rossini; Luigi De Gennaro
Journal:  Brain Sci       Date:  2017-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.